AU591077B2 - Prolonged-action immunotoxins containing a glycopeptide constituent which inactivates ribosomes, modified on its polysaccharide units - Google Patents

Prolonged-action immunotoxins containing a glycopeptide constituent which inactivates ribosomes, modified on its polysaccharide units

Info

Publication number
AU591077B2
AU591077B2 AU50783/85A AU5078385A AU591077B2 AU 591077 B2 AU591077 B2 AU 591077B2 AU 50783/85 A AU50783/85 A AU 50783/85A AU 5078385 A AU5078385 A AU 5078385A AU 591077 B2 AU591077 B2 AU 591077B2
Authority
AU
Australia
Prior art keywords
prolonged
glycopeptide
constituent
modified
polysaccharide units
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU50783/85A
Other versions
AU5078385A (en
Inventor
Pierre Gros
Franz Jansen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Publication of AU5078385A publication Critical patent/AU5078385A/en
Application granted granted Critical
Publication of AU591077B2 publication Critical patent/AU591077B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
    • A61K47/6817—Toxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6889—Conjugates wherein the antibody being the modifying agent and wherein the linker, binder or spacer confers particular properties to the conjugates, e.g. peptidic enzyme-labile linkers or acid-labile linkers, providing for an acid-labile immuno conjugate wherein the drug may be released from its antibody conjugated part in an acidic, e.g. tumoural or environment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Abstract

Prolonged-acting immunotoxin consisting of a conjugate in which an antibody or antibody fragment is coupled, via a covalent structure containing a disulphide group or a thioether group, to a ribosome-inactivating glycoprotein having a prolonged action obtained by oxidation of its saccharide moieties with periodate ions.
AU50783/85A 1985-02-13 1985-12-05 Prolonged-action immunotoxins containing a glycopeptide constituent which inactivates ribosomes, modified on its polysaccharide units Ceased AU591077B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8502068A FR2577135B1 (en) 1985-02-13 1985-02-13 LONG-TERM ACTION IMMUNOTOXINS COMPRISING A GLYCOPEPTITIDE CONSTITUENT MODIFYING RIBOSOMES MODIFIED ON ITS POLYSACCHARIDE PATTERNS
FR8502068 1985-02-13

Publications (2)

Publication Number Publication Date
AU5078385A AU5078385A (en) 1986-08-14
AU591077B2 true AU591077B2 (en) 1989-11-30

Family

ID=9316241

Family Applications (1)

Application Number Title Priority Date Filing Date
AU50783/85A Ceased AU591077B2 (en) 1985-02-13 1985-12-05 Prolonged-action immunotoxins containing a glycopeptide constituent which inactivates ribosomes, modified on its polysaccharide units

Country Status (14)

Country Link
EP (1) EP0192002B1 (en)
JP (1) JPH0725701B2 (en)
KR (1) KR930003333B1 (en)
AT (1) ATE75487T1 (en)
AU (1) AU591077B2 (en)
CA (1) CA1264667A (en)
DE (1) DE3585951D1 (en)
DK (1) DK563585A (en)
FR (1) FR2577135B1 (en)
GR (1) GR852914B (en)
IE (1) IE59909B1 (en)
NZ (1) NZ214482A (en)
PT (1) PT81623B (en)
ZA (1) ZA859299B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2566271B1 (en) * 1984-06-20 1986-11-07 Sanofi Sa NOVEL CYTOTOXIC CONJUGATES FOR USE IN THERAPEUTICS AND PROCESS FOR OBTAINING SAME
FR2573656B1 (en) * 1984-11-29 1987-02-27 Sanofi Sa MEDICINAL PRODUCT COMPRISING A COMBINATION OF AT LEAST ONE IMMUNOTOXIN AND AT LEAST ONE MANNOSE-CONTAINING POLYMER
EP0303681B1 (en) * 1987-02-24 1992-10-14 Xoma Corporation Immunosuppression in immunotoxin based human therapy
US4981979A (en) * 1987-09-10 1991-01-01 Neorx Corporation Immunoconjugates joined by thioether bonds having reduced toxicity and improved selectivity
IT1249051B (en) * 1991-02-26 1995-02-11 Italfarmaco Spa IMMUNOTOXIN FROM ANTI-CD5 MONOCLONAL ANTIBODIES
US6146850A (en) * 1991-11-04 2000-11-14 Xoma Corporation Proteins encoding gelonin sequences
US5376546A (en) * 1991-11-04 1994-12-27 Xoma Corporation Analogs of ribosome-inactivating proteins
US5621083A (en) * 1991-11-04 1997-04-15 Xoma Corporation Immunotoxins comprising ribosome-inactivating proteins
US5837491A (en) * 1991-11-04 1998-11-17 Xoma Corporation Polynucleotides encoding gelonin sequences

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4340535A (en) * 1978-09-28 1982-07-20 C M Industries Cytotoxic products formed by covalent bonding of the A chain of ricin with an antibody and the process for their preparation and use
AU8251082A (en) * 1981-04-15 1983-04-21 Sanofi Production of human antimelanoma monoclonal antibody
AU9033482A (en) * 1981-11-20 1983-05-26 Sanofi Societe Anonyme Conjugate of ricin chain a and monoclonal antibody

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL47372A (en) * 1975-05-27 1979-10-31 Yeda Res & Dev Fab'dimers bound to daunomycin or adriamycin,their preparation and pharmaceutical compositions containing same
JPS5616418A (en) * 1979-07-20 1981-02-17 Teijin Ltd Antitumor protein complex and its preparation
EP0044167A3 (en) * 1980-07-14 1982-04-21 The Regents Of The University Of California Antibody targeted cytotoxic agent
JPS5843926A (en) * 1981-09-08 1983-03-14 Suntory Ltd Selective carcinostatic agent
CA1203164A (en) * 1982-03-09 1986-04-15 Thomas J. Mckearn Antibody conjugates
PT80662B (en) * 1984-06-20 1986-12-09 Sanofi Sa Process to obtain anti-tumoral glycoprotein modified on its glycidic portions

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4340535A (en) * 1978-09-28 1982-07-20 C M Industries Cytotoxic products formed by covalent bonding of the A chain of ricin with an antibody and the process for their preparation and use
AU8251082A (en) * 1981-04-15 1983-04-21 Sanofi Production of human antimelanoma monoclonal antibody
AU9033482A (en) * 1981-11-20 1983-05-26 Sanofi Societe Anonyme Conjugate of ricin chain a and monoclonal antibody

Also Published As

Publication number Publication date
ATE75487T1 (en) 1992-05-15
ZA859299B (en) 1986-08-27
KR860006482A (en) 1986-09-11
FR2577135A1 (en) 1986-08-14
KR930003333B1 (en) 1993-04-26
JPS61200925A (en) 1986-09-05
IE853071L (en) 1986-08-13
NZ214482A (en) 1989-08-29
EP0192002B1 (en) 1992-04-29
CA1264667A (en) 1990-01-23
JPH0725701B2 (en) 1995-03-22
DE3585951D1 (en) 1992-06-04
DK563585A (en) 1986-08-14
IE59909B1 (en) 1994-04-20
EP0192002A1 (en) 1986-08-27
GR852914B (en) 1986-04-07
PT81623A (en) 1986-01-01
DK563585D0 (en) 1985-12-05
AU5078385A (en) 1986-08-14
FR2577135B1 (en) 1989-12-15
PT81623B (en) 1988-04-21

Similar Documents

Publication Publication Date Title
AU591077B2 (en) Prolonged-action immunotoxins containing a glycopeptide constituent which inactivates ribosomes, modified on its polysaccharide units
ES550152A0 (en) STABLE POLYSACCHARIDE-PROTEIN CONJUGATES
ATE76752T1 (en) BLOOD SUBSTITUTE.
AU1954692A (en) High-glyceryl, low-acetyl gellan gum for non-brittle gels
AU549495B2 (en) Immunoglobulin-vindesine conjugates
NZ221065A (en) Conjugates of antibodies and toxins with sulphur-containing linking groups
NZ235316A (en) Vaccine containing capsular polysaccharide conjugated to recombinant c protein of a group b streptococcus, production and use against b streptococcus infection
PT80662A (en) Process to obtain anti-tumoral glycoprotein modified on its glycidic portions
CA2036507A1 (en) 2'-deoxy-2'-methylidenecytidine dihydrate, methods for its production and compositions
GR3022411T3 (en) Low gloss bondable stretched film for envelope windows.
EP0776907A3 (en)
HUT53129A (en) Process for producing heparin fractions having anti-hiv activity
ES284927U (en) Hinge for visors-quitasol of vehicles (Machine-translation by Google Translate, not legally binding)
ES2003794A6 (en) Automatic door of replacement articulated sheets (Machine-translation by Google Translate, not legally binding)
ES290440U (en) Box transporter (Machine-translation by Google Translate, not legally binding)